来自海洋鱼类衍生的真菌Trichoderma sp. 的抗炎单体基基类药物. 在G1313中使用
Yuhan Zhang1, Yi Zhang2, Gang Li3
1Department of Natural Medicinal Chemistry and Pharmacognosy, School of Pharmacy, Qingdao University, Qingdao, Shandong 266071, People's Republic of China; Drug Supply Department, Qingdao West Coast New Area Central Hospital, Shandong 266555, People's Republic of China.
Fitoterapia
|April 17, 2024
概括
海洋真菌Trichoderma sp. 在海洋中生长. G13产生了四种新的三类 (1-4) 和已知的类. 这些化合物被评估为抗炎性质,其中化合物1-4显示中度氧化物 (NO) 抑制.
科学领域:
- 自然产品 化学 化学
- 海洋微生物学 海洋微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 海洋衍生真菌是新型生物活性化合物的丰富来源.
- 众所周知,Trichoderma物种可以产生多种不同的二次代谢产物.
- 索尔比基类药物代表了一类具有潜在治疗应用的真菌代谢物.
研究的目的:
- 从一种来自海洋的真菌中分离和描述新的菌素.
- 为了评估分离的化合物的抗炎潜力.
主要方法:
- 使用色谱技术分离和净化化合物.
- 使用核磁共振 (NMR),高分辨率电子喷雾电离质谱法 (HRESIMS) 和电子循环二元化 (ECD) 的结构阐明.
- 在体外抗炎测定测量氧化物 (NO) 在脂聚糖 (LPS) 激活的RAW264.7巨细胞中的产量.
主要成果:
- 确定了四种新的单体基基化物,三基化物AD-D (1-4).
- 还分离了两个已知的二度和五个已知的单质类类素 (5-11).
- 化合物1-4通过抑制NO生产,表现出中度的抗炎活性,IC50值在14至20μM之间.
结论:
- 在海洋的真菌Trichoderma sp. G13可以产生新型的菌素.
- 三氨基酸AD具有适度的抗炎性质,需要进一步研究.
相关概念视频
Combined Effects of Drugs: Synergism
6.2K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.2K
Production of Antibiotics
265
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
265
Inhibitors of Gram-positive Cell Wall Synthesis
191
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
191
Inhibitors of Bacterial Protein Synthesis
106
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
106
Antifungal Agents
119
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
119


